Hear insights from experts: Dr Aline Chaves, Prof. Makoto Tahara and Dr Ranee Mehra explore the rationale and latest data for immunotherapy-based and targeted treatments in development for recurrent/metastatic SCCHN.
Watch now: touchoncologyime.org/future-t...
This activity is funded by an independent medical education grant from Seagen Inc. and Genmab US, Inc., and is jointly provided by USF Health and touchIME.
Негізгі бет What’s on the horizon to tackle unmet needs in recurrent/metastatic SCCHN?
Пікірлер